[Metabolic changes of plasma XXXX levels in acute @entity542 ].

@entity1 @entity101 @entity3126 @entity16 @entity542 @entity772 @entity4478 @entity591 @entity2922 @entity1566 @entity717 @entity1063 @entity65
The plasma @entity2922 levels have been accepted as an index of sympathetic nervous activity in @entity16 . It is known that the plasma @entity1063 (NE) level is thought to reflect the degree of sympathetic nervous activity. NE is the neurotransmitter released from sympathetic nerve endings. In recent years several studies have suggested the role of biogenic @entity4478 in brain and @entity1566 . @entity542 is almost always associated with systemic changes. @entity1 with @entity542 often exhibit @entity65 , @entity101 , @entity591 , electrocardiographic abnormalities and @entity3126 which are regarded as signs of increased sympathetic nervous system activity. The present study was undertaken to examine whether the measurement of plasma NE levels is valuable to assess and evaluate clinical status of @entity1 with acute @entity542 . Sixty @entity1 with acute @entity542 admitted to our Department were studied. Fourty seven @entity1 were male and thirteen @entity1 were female, ages ranged from 2 to 70 years. All @entity1 were diagnosed by CT scan within three hours after @entity542 . Serial blood samples were also obtained during the first 7 days after @entity542 . The plasma NE was measured by high performance liquid chromatography. The Glasgow @entity772 Score (GCS) and the Japan @entity772 Scale (JCS) were recorded at admission for all @entity1 . Clinical outcome was assessed at the time of discharge according to the Glasgow Outcome Scale. The "good" group consisted of @entity1 with good recovery or moderate disability. The "poor" group consisted of @entity1 with @entity717 and persistent vegetative state and the "dead" group.(ABSTRACT TRUNCATED AT 250 WORDS)
